FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2901168769> ?p ?o ?g. }

• W2901168769 endingPage "2816" @default.
• W2901168769 startingPage "2808" @default.
• W2901168769 abstract "Background: Several studies have shown that detection of minimal residual disease (MRD) in acute myeloid leukemia (AML) is an independent prognostic factor. This study aimed to evaluate the significance of dynamic MRD pretransplantation on outcome of AML patients receiving allogeneic hematopoietic stem cell transplantation (allo-HSCT). Methods: We retrospectively analyzed 145 consecutive AML patients undergoing allo-HSCT in complete remission status between June 2013 and June 2016. MRD was determined with multiparameter flow cytometry after the first and second courses of chemotherapy and pre-HSCT. Results: In matched sibling donor transplantation (MSDT) settings, patients with positive MRD had higher cumulative incidence of relapse (CIR) than those without MRD after the first (32.3 ± 9.7% vs. 7.7 ± 3.1%, χ2 = 3.661, P = 0.055) or second course of chemotherapy (57.1 ± 3.6% vs. 12.5 ± 2.7%, χ2 = 8.759, P = 0.003) or pre-HSCT (50.0 ± 9.7% vs. 23.0 ± 3.2%, χ2 = 5.547, P = 0.019). In haploidentical SCT (haplo-SCT) settings, the MRD status at those timepoints had no significant impact on clinical outcomes. However, patients with persistent positive MRD from chemotherapy to pre-HSCT had higher CIR than those without persistent positive MRD both in MSDT and haplo-SCT settings. Patients with persistent positive MRD underwent MSDT had the highest relapse incidence, followed by those with persistent positive MRD underwent haplo-SCT, those without persistent MRD underwent haplo-SCT, and those without persistent MRD underwent MSDT (66.7 ± 9.2% vs. 38.5 ± 6.0% vs. 18.8 ± 8.7% vs. 12.0 ± 1.0%, χ2 = 20.763, P < 0.001). Multivariate analysis showed that persistent positive MRD before transplantation was associated with higher CIR (hazard ratio [HR] = 1.69, 95% confidence interval [CI]: 1.200–2.382, P = 0.003), worse leukemia-free survival (HR = 1.812, 95% CI: 1.168–2.812, P = 0.008), and overall survival (HR = 2.354, 95% CI: 1.528–3.627, P < 0.001). Conclusion: Our results suggest that persistent positive MRD before transplantation, rather than positive MRD at single timepoint, could predict poor outcome both in MSDT and haplo-SCT settings." @default.
• W2901168769 created "2018-11-29" @default.
• W2901168769 creator A5035282947 @default.
• W2901168769 creator A5037029781 @default.
• W2901168769 creator A5041756956 @default.
• W2901168769 creator A5046424825 @default.
• W2901168769 creator A5046425059 @default.
• W2901168769 creator A5047641392 @default.
• W2901168769 creator A5051030924 @default.
• W2901168769 creator A5051211027 @default.
• W2901168769 creator A5053573876 @default.
• W2901168769 creator A5061407928 @default.
• W2901168769 creator A5065894155 @default.
• W2901168769 creator A5067057238 @default.
• W2901168769 creator A5072208411 @default.
• W2901168769 creator A5078632164 @default.
• W2901168769 creator A5081663648 @default.
• W2901168769 creator A5084854649 @default.
• W2901168769 creator A5087610827 @default.
• W2901168769 date "2018-12-05" @default.
• W2901168769 modified "2023-10-14" @default.
• W2901168769 title "Association of Persistent Minimal Residual Disease with Poor Outcomes of Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation" @default.
• W2901168769 cites W1530764705 @default.
• W2901168769 cites W1597142907 @default.
• W2901168769 cites W1963777403 @default.
• W2901168769 cites W1971455987 @default.
• W2901168769 cites W1979938644 @default.
• W2901168769 cites W1982247089 @default.
• W2901168769 cites W1997998157 @default.
• W2901168769 cites W2005410572 @default.
• W2901168769 cites W2007990409 @default.
• W2901168769 cites W2038242472 @default.
• W2901168769 cites W2042814209 @default.
• W2901168769 cites W2060578002 @default.
• W2901168769 cites W2071206691 @default.
• W2901168769 cites W2090420626 @default.
• W2901168769 cites W2104411649 @default.
• W2901168769 cites W2107810465 @default.
• W2901168769 cites W2118250079 @default.
• W2901168769 cites W2133262115 @default.
• W2901168769 cites W2141034604 @default.
• W2901168769 cites W2161938647 @default.
• W2901168769 cites W2214515641 @default.
• W2901168769 cites W2242834385 @default.
• W2901168769 cites W2290759365 @default.
• W2901168769 cites W2409904921 @default.
• W2901168769 cites W2464644019 @default.
• W2901168769 cites W2513938433 @default.
• W2901168769 cites W2514964903 @default.
• W2901168769 cites W2591084969 @default.
• W2901168769 cites W2592430869 @default.
• W2901168769 cites W2727410306 @default.
• W2901168769 cites W2754341187 @default.
• W2901168769 cites W2789496953 @default.
• W2901168769 cites W2794126755 @default.
• W2901168769 cites W3149097951 @default.
• W2901168769 doi "https://doi.org/10.4103/0366-6999.246072" @default.
• W2901168769 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6278188" @default.
• W2901168769 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30511683" @default.
• W2901168769 hasPublicationYear "2018" @default.
• W2901168769 type Work @default.
• W2901168769 sameAs 2901168769 @default.
• W2901168769 citedByCount "6" @default.
• W2901168769 countsByYear W29011687692019 @default.
• W2901168769 countsByYear W29011687692021 @default.
• W2901168769 countsByYear W29011687692022 @default.
• W2901168769 crossrefType "journal-article" @default.
• W2901168769 hasAuthorship W2901168769A5035282947 @default.
• W2901168769 hasAuthorship W2901168769A5037029781 @default.
• W2901168769 hasAuthorship W2901168769A5041756956 @default.
• W2901168769 hasAuthorship W2901168769A5046424825 @default.
• W2901168769 hasAuthorship W2901168769A5046425059 @default.
• W2901168769 hasAuthorship W2901168769A5047641392 @default.
• W2901168769 hasAuthorship W2901168769A5051030924 @default.
• W2901168769 hasAuthorship W2901168769A5051211027 @default.
• W2901168769 hasAuthorship W2901168769A5053573876 @default.
• W2901168769 hasAuthorship W2901168769A5061407928 @default.
• W2901168769 hasAuthorship W2901168769A5065894155 @default.
• W2901168769 hasAuthorship W2901168769A5067057238 @default.
• W2901168769 hasAuthorship W2901168769A5072208411 @default.
• W2901168769 hasAuthorship W2901168769A5078632164 @default.
• W2901168769 hasAuthorship W2901168769A5081663648 @default.
• W2901168769 hasAuthorship W2901168769A5084854649 @default.
• W2901168769 hasAuthorship W2901168769A5087610827 @default.
• W2901168769 hasBestOaLocation W29011687691 @default.
• W2901168769 hasConcept C120665830 @default.
• W2901168769 hasConcept C121332964 @default.
• W2901168769 hasConcept C126322002 @default.
• W2901168769 hasConcept C143998085 @default.
• W2901168769 hasConcept C2776694085 @default.
• W2901168769 hasConcept C2777408962 @default.
• W2901168769 hasConcept C2778461978 @default.
• W2901168769 hasConcept C2778729363 @default.
• W2901168769 hasConcept C2779823535 @default.
• W2901168769 hasConcept C2911091166 @default.
• W2901168769 hasConcept C61511704 @default.
• W2901168769 hasConcept C71924100 @default.
• W2901168769 hasConcept C88879693 @default.

• next